Anti-FGFR2 antibodies and methods of use thereof
PH12023551047B1Active Publication Date: 2026-08-19REGENERON PHARMACEUTICALS INC
0 Cites 0 Cited by
Patent Information
- Application Number
- PH12023551047
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2023-04-17
- Publication Date
- 2026-08-19
- Estimated Expiration
- 2043-04-17
Abstract
Provided herein are monoclonal antibodies, and antigen-binding fragments thereof, that bind fibroblast growth factor receptor 2 (FGFR2), and methods of use thereof and methods of use thereof. Also included are antibody-drug conjugates (ADCs) comprising the anti-FGFR2 antibodies or antigen-binding fragments thereof linked to a cytotoxic agent, radionuclide, or other moiety, as well as methods of treatment using the same.
Need to check novelty before this filing date? Find Prior Art